Biofrontera (BFRI) Payables (2020 - 2025)
Historic Payables for Biofrontera (BFRI) over the last 6 years, with Q3 2025 value amounting to $6.6 million.
- Biofrontera's Payables rose 4077.34% to $6.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.6 million, marking a year-over-year increase of 4077.34%. This contributed to the annual value of $4.3 million for FY2024, which is 4907.64% down from last year.
- According to the latest figures from Q3 2025, Biofrontera's Payables is $6.6 million, which was up 4077.34% from $5.8 million recorded in Q2 2025.
- Biofrontera's Payables' 5-year high stood at $11.1 million during Q1 2023, with a 5-year trough of $3.9 million in Q2 2024.
- Over the past 5 years, Biofrontera's median Payables value was $8.5 million (recorded in 2022), while the average stood at $7.8 million.
- As far as peak fluctuations go, Biofrontera's Payables surged by 25676.27% in 2021, and later plummeted by 5783.13% in 2024.
- Quarter analysis of 5 years shows Biofrontera's Payables stood at $9.7 million in 2021, then grew by 12.53% to $10.9 million in 2022, then decreased by 22.76% to $8.4 million in 2023, then tumbled by 49.08% to $4.3 million in 2024, then surged by 53.36% to $6.6 million in 2025.
- Its last three reported values are $6.6 million in Q3 2025, $5.8 million for Q2 2025, and $4.6 million during Q1 2025.